Zansors, a wearable tech company based in Northern, Virginia, has added to its growing collection of patents. Zansors was recently awarded a patent for a wearable patch to automatically monitor, screen and/or report health conditions. Zansors’ next-generation intellectual property (IP) will allow health monitoring devices to detect sleeping or breathing disorders.

Respa, the world’s first breathing sensor and future of fitness, today announced findings from a three-month study conducted with Winthrop University to measure the effectiveness of detecting the onset of athletes’ ventilatory threshold.

Respa, the world’s first breathing analyzer, designed to improve athletic performance while running, yoga and other workout sessions, will look to integrate its technology with Amazon Alexa.

Respa, the world’s first breathing analyzer, designed to improve athletic performance while running, and during fitness workouts and yoga sessions, has been launched on Indiegogo.

Arlington, VA (December 19, 2017) -- Zansors labs has built the cloud components to allow sensors and apps to send data to medical institutions using the Direct standard, in compliance with Meaningful Use requirements.

Zansors and Blauer Manufacturing Inc. announced a partnership to introduce wearable technology in defense textiles, which can be used to improve safety and utility of gear for first responders and the military. Zansors’ innovative sensor technology will advance the utility of Blauer’s gear designed for police, fire, EMS and military.

ARLINGTON, VA. (May 16, 2017) - Zansors has secured a patent from U.S. Patent and Trademark Office (USPTO) for a wireless electrocardiogram (ECG or EKG) acquisition and monitoring device. This Zansors’ next-generation intellectual property (IP), will allow heart- monitoring devices to be integrated into clothing, or secured directly onto the skin, making them significantly easier to deploy and use.

Patent captures stackable adhesive layers for wearable patches that combine electronics and health monitoring
 

This additional, larger, Phase II grant from National Institutes of Health will continue support of research and commercialization of Zansors’ “first to market” wearable consumer sleep-apnea product

Zansors discusses small business access to global markets on a panel with the president.

Dr. Dasgupta will speak in the session Conditional Management with Mobile and Connected Health

Baabi Das, Founder and President of Zansors, will be co-presenting a session on Enabling Point-of-Care Diagnostics at the Next Generation Dx Summit with Zhenyu Li, Ph.D., Assistant Professor, School of Engineering and Applied Science, George Washington University on Tuesday, August 19th 2014. 

TYSONS, VA | June 5, 2014 – Zansors selected as a semi-finalist for the 2014 Big C Competition powered by LIVESTRONG

Zansors has been chosen as a presenting company for the American Telemedicine Assoication's (ATA) Venture Summit on May 18, 2014 and Zansors will present during ATA's Innovation Spotlight on May 19, 2014.

We’re proud to announce that Zansors has been named a finalist at next month's AARP Health Innovation @50+ LivePitch!